Browse studies

Find your next paid study

26,402 recruiting studies available now

Evaluating Adjuvant Atezolizumab or Atezolizumab and Hyaluronidase-TQJS to Prevent Recurrence in Stage I Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase III Trial (AASI-NSCLC)

This phase III trial compares the effect of atezolizumab (or atezolizumab and recombinant human hyaluronidase) to standard observation for preventing cancer re…

Lung Non-Small Cell Carcinoma

Estimated

~$50 – $1,350

Actual pay is set by the research site.

National Cancer Institute (NCI)NCT07388524

Phase 2

A Phase 2 Study of Blinatumomab in Combination With Chemotherapy for Infants With Newly Diagnosed Acute Lymphoblastic Leukemia With Randomization of KMT2A-Rearranged Patients to Addition of Venetoclax

This phase II trial tests the addition of venetoclax and/or blinatumomab to usual chemotherapy for treating infants with newly diagnosed acute lymphoblastic le…

Acute Leukemia of Ambiguous LineageB Acute Lymphoblastic Leukemia

Estimated

~$75 – $1,800

Actual pay is set by the research site.

National Cancer Institute (NCI)NCT06317662

Observational

Effectivity of P1821, a Novel Tongue Strengthening and Endurance Enhancing Speech Flow Exercise

The P1821 initiative constitutes an innovative intervention specifically engineered to enhance tongue muscular strength and endurance. The primary objective of…

AnkyloglossiaImpairment of SpeechSlurred Speech

Estimated

~$10 – $1,050

Actual pay is set by the research site.

Dream Video LLCNCT07719582

Phase 3

DAREON ® -Lung-1: A Phase III Multi-center, Open-label, Randomised Trial of Intravenous Obrixtamig in Combination With Atezolizumab, Carboplatin, and Etoposide vs. Atezolizumab, Carboplatin, and Etoposide as First-line Treatment in Patients With Extensive-stage Small Cell Lung Cancer

This study is open to adults with advanced small cell lung cancer (SCLC). The purpose of this study is to find out if a study medicine called obrixtamig plus s…

Small Cell Lung Cancer (SCLC)Extensive-stage Small Cell Lung Cancer (ES-SCLC)

Estimated

~$50 – $2,250

Actual pay is set by the research site.

Boehringer IngelheimNCT07472517

Phase 4

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Dupilumab on Airway Inflammation Through Assessments of Mucus Plugging and Other Lung Imaging Parameters in Patients With Chronic Obstructive Pulmonary Disease.

LPS18583 is a multinational, randomized, double-blind, placebo-controlled, parallel-group, Phase 4 study with 2 treatment groups. The purpose of this study is …

Chronic Obstructive Pulmonary Disease

Estimated

~$25 – $1,500

Actual pay is set by the research site.

SanofiNCT07053423

Phase 3

A Phase 3, Randomized, Double-Masked, Active-Controlled Trial of a Single Intravitreal Injection of 4D-150 in Adults With Macular Neovascularization Secondary to Age-Related Macular Degeneration

This Phase 3 study is evaluating the safety and efficacy of 4D-150 versus aflibercept in participants with neovascular age-related macular degeneration (nAMD).…

Neovascular Age-Related Macular Degeneration (nAMD)

Estimated

~$50 – $2,100

Actual pay is set by the research site.

4D Molecular TherapeuticsNCT07064759

Phase 1

A Phase I Dose Escalation-Expansion Trial of Sunitinib Malate Plus Lutetium Lu 177 Dotatate (Lutathera) in Somatostatin Receptor Positive Pancreatic Neuroendocrine Tumors

This phase I trial tests the safety, side effects, and best dose of sunitinib malate in combination with lutetium Lu 177 dotatate in treating patients with pan…

Metastatic Pancreatic Neuroendocrine TumorPancreatic NeoplasmStage III Pancreatic Neuroendocrine Tumor AJCC v8+2 more

Estimated

~$150 – $2,700

Actual pay is set by the research site.

National Cancer Institute (NCI)NCT05687123

Screening Protocol for Subjects Being Evaluated for National Heart, Lung and Blood Institute (NHLBI) Protocols

This study allows the evaluation of subjects in order to determine their ability to safely participate in other active research studies. After subjects comple…

Hematologic Disease and DisordersDonorsHealthy Volunteer

Estimated

~$10 – $675

Actual pay is set by the research site.

National Heart, Lung, and Blood Institute (NHLBI)NCT00001620

Observational

OPTImal Ventilation to Improve Pediatric Cardiac Arrest Outcomes (OPTI-VENT)

Pediatric cardiac arrest is a life-threatening problem affecting \>15,000 hospitalized children each year. Less than half of these children survive to hospital…

Cardiac Arrest (CA)

Estimated

~$10 – $750

Actual pay is set by the research site.

Children's Hospital of PhiladelphiaNCT07114510

Improving Implementation of Guideline-Recommended LDL-C Management in High-Risk Cardiovascular Patients: A Multilevel Implementation Science Study

The goal of this observational study is to learn whether implementing evidence-based strategies in cardiology practices can improve guideline-recommended low-d…

ASCVD

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Cardiology Consultants of PhiladelphiaNCT07883564

Phase 1

A Pilot Study of an Implantable Microdevice for In Situ Evaluation of Drug Response in Patients With Primary Brain Tumors

This pilot study will assess the safety and feasibility of using an implantable microdevice to measure local intratumor response to chemotherapy and other clin…

Grade II GliomaGrade III GliomaGrade IV Glioma+5 more

Estimated

~$150 – $4,500

Actual pay is set by the research site.

Oliver JonasNCT04135807

Phase 3

A Phase 3b, Multicenter, Two Stage, Double-blind, Long Term Follow up and Open Label Extension Study of Participants Who Have Completed the CBL-0301 or CBL-0302 Study for Reducing Abdominal Subcutaneous Fat (Stage 1)

A Phase 3b, Multicenter, Two stage, Double-blind, Long term Follow up and Open-label Extension Study of Participants Who have Completed the CBL-0301 or CBL-030…

Subcutaneous Fat

Estimated

~$50 – $2,100

Actual pay is set by the research site.

Caliway Biopharmaceuticals Co., Ltd.NCT07733947